Skip to main content

Table 2 Univariate and multivariate analyses to identified factors predicting severe PHLF

From: Impact of aspartate aminotransferase–to–platelet ratio index based score to assess posthepatectomy liver failure in patients with hepatocellular carcninoma

Variables

Odds ratio

95% CI

P value

Odds ratio

95% CI

P value

PALBI

6.98

2.07–23.6

0.0021*

3.81

0.65–22.3

0.1385

FIB-4 index

1.03

0.99–1.06

0.1674

   

APRI

1.36

1.15–1.62

0.0009**

1.32

1.05–1.65

0.0230*

ALPlat index

0.99

0.98–0.99

0.0106*

0.99

0.99–1.00

0.9852

ICG-R15 (%)

1.05

1.01–1.08

0.0070*

1.02

0.97–1.06

0.4890

MELD score

1.43

1.221.68

< 0.0001**

1.44

1.15–1.80

0.0020*

Operating time (min)

1.01

1.00–1.01

< 0.0001**

1.01

1.00–1.01

0.0019*

Intraoperative blood loss (mL)

1.00

1.00–1.00

< 0.0001**

1.00

1.00–1.00

0.0278*

  1. ALPlat index platelet count + 90 × albumin, APRI AST-to-platelet ratio index, AST asparate aminotransferase, CI confidence interval, FIB-4 fibrosis-4, ICG-R15 indocyanine green dye retention rate at 15 min, MELD model for end-stage liver disease, PALBI platelet-albumin-bilirubin, PHLF posthepatectomy liver failure *P < 0.05 and **P < 0.001